These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. No rise in glomerular filtration rate after protein load in severe liver disease. Hirschberg R; von Herrath D; Pauls A; Schaefer K Lancet; 1984 Nov; 2(8410):1047-8. PubMed ID: 6149435 [No Abstract] [Full Text] [Related]
47. Letter: Prostaglandins and asthma. Smith AP; Dunlop L Lancet; 1975 Jan; 1(7897):39. PubMed ID: 46356 [No Abstract] [Full Text] [Related]
48. Does routine estimation of glomerular filtration rate in cirrhotics help? Kher V Indian J Gastroenterol; 1994 Jul; 13(3):77-8. PubMed ID: 8076984 [No Abstract] [Full Text] [Related]
49. Warily considering a new method for evaluating renal function. Kanno Y Radiology; 2012 Jan; 262(1):373; author reply 373. PubMed ID: 22190667 [No Abstract] [Full Text] [Related]
50. The effect of protein on renal function in cirrhosis. Sweeting J Gastroenterology; 1990 Sep; 99(3):895. PubMed ID: 2379792 [No Abstract] [Full Text] [Related]
51. The adaptive role of renal prostaglandin production: current clinical problems and future clinical horizons. Zawada ET Nephron; 1984; 36(2):77-9. PubMed ID: 6694782 [No Abstract] [Full Text] [Related]
53. Reply: Liver, heart, and kidney crosstalk in cirrhosis: POCUS is the focus. Premkumar M; Kajal K; Izzy M; Sihag BK Hepatology; 2024 Jul; 80(1):E19-E20. PubMed ID: 38373096 [No Abstract] [Full Text] [Related]
54. Letter to the Editor: Liver, heart, and kidney crosstalk in cirrhosis: POCUS is the focus. Agrawal D; Ariga KK Hepatology; 2024 Jul; 80(1):E17-E18. PubMed ID: 38353571 [No Abstract] [Full Text] [Related]
55. Multiple metabolic renal manifestations of a systemic disease. Hanouneh M; Monroy Trujillo JM Cleve Clin J Med; 2024 Mar; 91(3):155-160. PubMed ID: 38429003 [No Abstract] [Full Text] [Related]